Why the study?
Salvianolate injection is widely used in cardiovascular disease treatment, but the mechanism by which it alleviates cardiotoxicity remains unclear.
Does salvianolate ameliorate doxorubicin- or azithromycin-induced cardiotoxicity by regulating autophagic flux in a zebrafish model?
Does salvianolate ameliorate doxorubicin- or azithromycin-induced cardiotoxicity by regulating autophagic flux in a zebrafish model?
This preclinical study demonstrates that salvianolate mitigates doxorubicin- and azithromycin-induced cardiotoxicity in zebrafish by promoting cardiomyocyte autophagic flux via the miR-30a/becn1 axis, suggesting its potential as an adjunctive cardioprotective agent.
Answers are grounded in this paper and cite their sources.
Salvianolate may mitigate drug-induced cardiac injury in larvae; leaves open translation to human cardiotoxicity prevention.
BACKGROUND: Salvianolate is a compound mainly composed of salvia magnesium acetate, which is extracted from the Chinese herb Salvia miltiorrhiza . In recent years, salvianolate injection has been widely used in the treatment of cardiovascular diseases, but the mechanism of how it can alleviate cardiotoxicity remains unclear. METHODS: The cardiac injury model was constructed by treatment with doxorubicin (Dox) or azithromycin (Azi) in zebrafish larvae. Heart phenotype, heart rate, and cardiomyocyte apoptosis were observed in the study. RNA-sequencing (RNA-seq) analysis was used to explore the underlying mechanism of salvianolate treatment. Moreover, cardiomyocyte autophagy was assessed by in situ imaging. In addition, the miR-30a/becn1 axis regulation by salvianolate was further investigated. RESULTS: Salvianolate treatment reduced the proportion of pericardial edema, recovered heart rate, and inhibited cardiomyocyte apoptosis in Dox/Azi-administered zebrafish larvae. Mechanistically, salvianolate regulated the lysosomal pathway and promoted autophagic flux in zebrafish cardiomyocytes. The expression level of becn1 was increased in Dox-induced myocardial tissue injury after salvianolate administration; overexpression of becn1 in cardiomyocytes alleviated the Dox/Azi-induced cardiac injury and promoted autophagic flux in cardiomyocytes, while becn1 knockdown blocked the effects of salvianolate. In addition, miR-30a, negatively regulated by salvianolate, partially inhibited the cardiac amelioration of salvianolate by targeting becn1 directly. CONCLUSION: This study has proved that salvianolate reduces cardiomyopathy by regulating autophagic flux through the miR-30a/becn1 axis in zebrafish and is a potential drug for adjunctive Dox/Azi therapy.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: